Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of Etrasimod in Adult Subjects with Eosinophilic Esophagitis
2020-003226-23Phase 2Completed
- Sponsor
- Arena Pharmaceuticals, Inc.
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in eosinophilic esophagitis (EoE) comparing Etrasimod with Placebo (2 arms). Primary endpoint: Percent change from baseline in esophageal PEC at Week 16. Started Nov 2020; status: completed.
02
Drugs
etrasimod
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on 2020-003226-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003226-23.